Reference : Progression model tissue microarray (TMA) for the study of uterine carcinomas.
Scientific journals : Article
Human health sciences : Oncology
http://hdl.handle.net/2268/77374
Progression model tissue microarray (TMA) for the study of uterine carcinomas.
English
Arafa, Mohammad mailto [> > > >]
Boniver, Jacques mailto [Centre Hospitalier Universitaire de Liège - CHU > > Anatomie pathologique >]
Delvenne, Philippe mailto [Université de Liège - ULg > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques >]
2010
Disease Markers
IOS Press
28
5
267-72
Yes (verified by ORBi)
International
0278-0240
Amsterdam
The Netherlands
[en] Disease Progression ; Female ; Humans ; Models, Biological ; Tissue Array Analysis ; Uterine Cervical Neoplasms/diagnosis/therapy
[en] Cervical and endometrial uterine carcinomas are heterogeneous groups of cancers, which are preceded by preneoplastic lesions. More accurate tools are needed to improve the diagnosis and to define markers which may be relevant for the diagnosis, prediction of disease progression and therapeutic response.High throughput technologies for testing and validating molecular targets in cancer lesions and in their precursors are presently available. Among them, the tissue microarray (TMA) presents the advantage of a morphological control of the analyzed tissue fragment. In this article, we review the different aspects of the TMA technology with a special consideration to a uterine carcinogenesis model.
Giga-Cancer
http://hdl.handle.net/2268/77374
10.3233/DMA-2010-0709

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
10 TMA (DMA) reprints.PDFPublisher postprint979.82 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.